KR101814744B1 - Manufacturing method of composition for inhibiting skin aging using donkey skin - Google Patents

Manufacturing method of composition for inhibiting skin aging using donkey skin Download PDF

Info

Publication number
KR101814744B1
KR101814744B1 KR1020160139335A KR20160139335A KR101814744B1 KR 101814744 B1 KR101814744 B1 KR 101814744B1 KR 1020160139335 A KR1020160139335 A KR 1020160139335A KR 20160139335 A KR20160139335 A KR 20160139335A KR 101814744 B1 KR101814744 B1 KR 101814744B1
Authority
KR
South Korea
Prior art keywords
collagen
donkey
skin
weight
extraction
Prior art date
Application number
KR1020160139335A
Other languages
Korean (ko)
Inventor
장애라
김동욱
김정수
김한나
이신영
Original Assignee
천유화장품(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 천유화장품(주) filed Critical 천유화장품(주)
Priority to KR1020160139335A priority Critical patent/KR101814744B1/en
Application granted granted Critical
Publication of KR101814744B1 publication Critical patent/KR101814744B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/985Skin or skin outgrowth, e.g. hair, nails
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a method of manufacturing a composition for suppressing aging by using donkey skin. More specifically, the method includes: a material pretreatment step of pretreating donkey skin; a collagen extracting step of mixing the pretreated donkey skin with water, extracting collagen at a high temperature and pressure, and filtering the mixture; a collagen decomposing step of decomposing collagen by mixing proteolysis enzymes with the collagen decomposed and extracted through the collagen decomposing step; an enzyme inactivating step of inactivating enzymes contained in the decomposed collagen; and a filtering step of filtering the decomposed collagen having the enzymes inactivated through the inactivating step. The composition for suppressing aging is capable of improving wrinkles and preventing skin aging, and minimizing stimulation to skin by omitting an alkaline or acidic treatment procedure.

Description

당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법 {MANUFACTURING METHOD OF COMPOSITION FOR INHIBITING SKIN AGING USING DONKEY SKIN}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for inhibiting skin aging using a donkey skin,

개시된 내용은 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법에 관한 것으로, 더욱 상세하게는 알칼리나 산처리과정을 거치지 않아 피부자극이 적고, 우수한 피부노화 방지 및 주름 개선 효과를 나타내는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법에 관한 것이다.
The present invention relates to a method for producing a composition for inhibiting skin aging using a donkey skin, and more particularly, to a method for preparing a composition for preventing aging of a skin using a donkey shell, which is less susceptible to skin irritation due to no alkali or acid treatment, And a method for producing a composition for inhibiting skin aging.

한국의 65세 이상 노인의 수는 해마다 지속적으로 증가하고 있으며, 2050년에는 전체인구의 37%가 노인인구로 편입될 것으로 예상되는데, 이는 다른 나라에 비해 노인인구의 비율이 매우 높은 상태다. 따라서, 젊은 층뿐만 아니라 노령층의 피부노화에 대한 관심이 높아질 것으로 예상되며, 보다 넓은 범위의 소비자층에서 피부노화에 대한 대비책이 요구되고 있다.The number of elderly people aged 65 or older in Korea is steadily increasing year by year. In 2050, 37% of the total population is expected to be included in the elderly population, which is much higher than in other countries. Therefore, it is anticipated that interest in skin aging of older people as well as younger age will be heightened, and a wider range of consumers are demanding measures against skin aging.

피부 노화의 원인은 외재적 요인과 내재적 요인으로 나누어 구분할 수 있는데, 외재적 요인으로는 일상생활 방식 인자로 예를 들어 자외선, 환경오염, 흡연 및 스트레스 등이 있으며, 내재적 요인으로는 나이 및 유전적 요인 등이 있다. 이 때, 노화 원인에 대한 유력한 매커니즘은 자외선에 의한 자유라디칼(free radical) 생성을 하는 광노화라 할 수 있다.The causes of skin aging can be classified into external factors and internal factors. Exogenous factors include daily life factors such as ultraviolet rays, environmental pollution, smoking and stress, and internal factors include age and genetic Factors. At this time, a potent mechanism for the cause of aging may be called photoaging that generates free radicals by ultraviolet rays.

특히, 자외선 중 UVB에 의해 DNA의 손상과 활성 산소종(reactive oxygen species, ROS)의 생성이 초래되어 피부질환 및 광 노화가 진행되는데, 피부는 비타민 E11, 비타민 C등과 같은 항산화 네트워크로 자유라디칼을 소멸시켜 피부를 보호하지만 오랜 시간이 경과함에 따라 그 기능이 점차 감소하여 피부노화가 진행되는 것이다.In particular, the ultraviolet rays UVB causes DNA damage and reactive oxygen species (ROS), resulting in skin diseases and photoaging. The skin is an antioxidant network such as vitamin E 11 and vitamin C, And protects the skin, but as the time elapses, its function gradually decreases and the skin ages.

또한, UVB의 노출은 피부 내 콜라겐을 감소하게 하여 주름이 형성되고, 색소 침착 또는 건조하고 거친 피부를 유발하기 때문에, 피부노화 방지를 위해 자유라디칼 생성을 억제할 수 있는 항산화 기능 소재 개발이 요구되며, 콜라게나아제(Collagenase)와 엘라스테이스(Elastase) 억제 기능을 통해 피부 주름과 같은 피부 질환을 억제할 수 있는 소재의 개발이 요구되고 있다.
In addition, exposure of UVB causes reduction of collagen in the skin to form wrinkles, causing pigmentation or drying and rough skin. Therefore, development of antioxidant functional material capable of inhibiting free radical generation is required to prevent skin aging , Collagenase and Elastase inhibiting function, it is required to develop a material capable of inhibiting skin diseases such as wrinkles of the skin.

한국특허등록 제10-1557409호(2015.09.25)Korean Patent Registration No. 10-1557409 (2015.09.25) 한국특허공개 제10-2012-0063693호(2012.06.18)Korean Patent Publication No. 10-2012-0063693 (June 18, 2012)

개시된 내용은 알칼리나 산처리과정을 거치지 않아 피부자극이 적고, 우수한 피부노화 방지 및 주름 개선 효과를 나타내는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법을 제공하는 것이다.
It is an object of the present invention to provide a method for producing a composition for inhibiting skin aging using a donkey shell showing less skin irritation due to no alkali or acid treatment and exhibiting excellent skin aging and wrinkle-reducing effects.

하나의 일 실시예로서 이 개시의 내용은 당나귀 껍질을 전처리하는 원료전처리단계, 상기 원료전처리단계를 통해 전처리된 당나귀 껍질을 물과 혼합하고 고온고압을 가하여 콜라겐을 추출하고 여과하는 콜라겐추출여과단계, 상기 콜라겐추출여과단계를 통해 추출 및 여과된 콜라겐에 단백질분해효소를 혼합하여 콜라겐을 분해하는 콜라겐분해단계, 상기 콜라겐분해단계를 통해 분해된 콜라겐 분해물에 함유된 효소를 불활성화하는 효소불활성화단계 및 상기 효소불활성화단계를 통해 효소가 불활성화된 콜라겐 분해물을 여과하는 여과단계로 이루어지는 것을 특징으로 하는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법에 대해 기술하고 있다.In one embodiment, the content of the disclosure includes a raw material pretreatment step for pretreating a donkey's skin, a collagen extraction filtration step in which a donkey's shell pretreated through the raw material pretreatment step is mixed with water, a high temperature and high pressure is applied to extract collagen, A collagen degradation step of decomposing collagen by mixing the proteolytic enzyme with the collagen extracted and filtered through the collagen extraction filtration step, an enzyme inactivation step of inactivating the enzyme contained in the collagen degradation product decomposed through the collagen decomposition step, And a filtration step of filtering the collagen decomposition product in which the enzyme is inactivated through the enzyme inactivation step. The method for producing the composition for inhibiting skin aging using the donkey skin is described.

바람직하기로는, 상기 콜라겐추출단계는 상기 원료전처리단계를 통해 전처리된 당나귀 껍질 100 중량부를 물 150 내지 250 중량부와 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제1추출여과단계 및 상기 제1추출여과단계를 통해 콜라겐이 추출된 당나귀 껍질 100 중량부를 물 80 내지 120 중량부와 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제2추출여과단계로 이루어질 수 있다.Preferably, the collagen extraction step at a temperature and a 1 to a pressure of 2kgf / cm 2 for mixing with the raw material pre-processing step the donkey shell of 100 parts by weight of water 150 to 250 parts by weight of pre-treatment with the 110 to 130 50 to 70 100 parts by weight of collagen-extracted donkey shells are mixed with 80 to 120 parts by weight of water through a first extraction and filtration step of extracting and filtering the mixture at a temperature of 110 to 130 ° C and 1 to 2 kgf / 2 and a second extraction filtration step of extracting and filtering at 50 to 70 minutes.

더 바람직하기로는, 상기 콜라겐분해단계는 상기 콜라겐추출여과단계를 통해 추출 및 여과된 콜라겐 100 중량부에 단백질분해효소 0.05 내지 0.2 중량부를 혼합하고 40 내지 50℃의 온도에서 2 내지 4시간 동안 이루어질 수 있다.More preferably, the collagen decomposing step comprises mixing 0.05 to 0.2 parts by weight of a protease with 100 parts by weight of the collagen extracted and filtered through the collagen extraction filtration step, at a temperature of 40 to 50 ° C for 2 to 4 hours have.

더욱 바람직하기로는, 상기 단백질분해효소는 판크레아제와 알카린프로테아제가 1:1의 중량부로 혼합되어 이루어질 수 있다.More preferably, the protease can be prepared by mixing pancreatin and alkaline protease in a weight ratio of 1: 1.

더욱 더 바람직하기로는, 상기 효소불활성화단계는 상기 콜라겐분해단계를 통해 분해된 콜라겐분해물을 85 내지 95℃의 온도로 10 내지 20분 동안 가열하여 이루어질 수 있다.Even more preferably, the enzyme inactivation step may be performed by heating the degraded collagen degraded through the collagen degradation step to a temperature of 85 to 95 ° C for 10 to 20 minutes.

더욱 더 바람직하기로는, 상기 여과단계는 분자량이 3kDa를 초과하는 성분을 걸러낼 수 있는 맴브레인 필터로 이루어질 수 있다.
Even more preferably, the filtration step may consist of a membrane filter capable of filtering out components having a molecular weight greater than 3 kDa.

이상에서와 같은 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법은 알칼리나 산처리과정을 거치지 않아 피부자극이 적고, 우수한 피부노화 방지 및 주름 개선 효과를 나타내는 당나귀 껍질을 이용한 피부노화 억제용 조성물을 제공하는 효과를 나타낸다.
The composition for inhibiting skin aging using the donkey skin as described above is a composition for inhibiting skin aging using a donkey shell showing less skin irritation and excellent skin aging resistance and anti-wrinkle effect due to no treatment with alkali or acid, .

도 1은 개시된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법을 나타낸 순서도이다.
도 2 내지 도 5는 실시예 1을 통해 제조된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 항산화 활성을 측정하여 나타낸 그래프이다.
도 6 내지 도 7은 실시예 1을 통해 제조된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 주름개선 효과를 측정하여 나타낸 그래프이다.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flowchart showing a method for producing a composition for inhibiting skin aging using the disclosed donkey's skin.
FIGS. 2 to 5 are graphs showing the antioxidative activities of compositions for inhibiting skin aging using the donkey bark prepared in Example 1. FIG.
FIGS. 6 to 7 are graphs showing the wrinkle-reducing effect of the composition for inhibiting skin aging using the donkey skin prepared in Example 1. FIG.

이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.
Hereinafter, preferred embodiments of the present invention and physical properties of the respective components will be described in detail with reference to the accompanying drawings. However, the present invention is not limited thereto, And this does not mean that the technical idea and scope of the present invention are limited.

개시된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법은 당나귀 껍질을 전처리하는 원료전처리단계(S101), 상기 원료전처리단계(S101)를 통해 전처리된 당나귀 껍질을 물과 혼합하고 고온고압을 가하여 콜라겐을 추출하고 여과하는 콜라겐추출여과단계(S103), 상기 콜라겐추출여과단계(S103)를 통해 추출 및 여과된 콜라겐에 단백질분해효소를 혼합하여 콜라겐을 분해하는 콜라겐분해단계(S105), 상기 콜라겐분해단계(S105)를 통해 분해된 콜라겐 분해물에 함유된 효소를 불활성화하는 효소불활성화단계(S107) 및 상기 효소불활성화단계(S107)를 통해 효소가 불활성화된 콜라겐 분해물을 여과하는 여과단계(S109)로 이루어진다.
A method for preparing a composition for inhibiting skin aging using the disclosed donkey shell comprises a raw material preprocessing step (S101) for pretreating a donkey shell, a donkey shell pretreated through the raw material preprocessing step (S101), water and collagen A collagen decomposition step (S105) for decomposing collagen by mixing the proteolytic enzyme extracted and filtered through the collagen extraction filtration step (S103) (S105), the collagen decomposition step (S103) (S107) for inactivating an enzyme contained in the collagen degradation product decomposed through the enzyme inactivation step (S105) and a filtration step (S109) for filtering the collagen decomposition product in which the enzyme is inactivated through the enzyme inactivation step (S107) .

상기 원료전처리단계(S101)는 당나귀 껍질을 전처리하는 단계로, 당나귀 껍질을 수세 및 가열하고, 지방층을 제거하여 이루어진다.The raw material preprocessing step (S101) is a step of pretreating the donkey's skin, washing and heating the donkey's skin, and removing the fat layer.

상기 수세는 당나귀 껍질을 흐르는 물로 수세하여 당나귀 껍질에 잔존하는 털이나 불순물 등을 제거하는 과정이며, 상기 가열은 수세된 당나귀 껍질을 끓는 물에 투입하여 15 내지 25분 동안 가열하는 과정을 통해 당나귀 껍질에 잔존하는 털, 불순물 및 기름층을 제거하는 과정이다.The water is washed with water flowing through the donkey shell to remove hair and impurities remaining in the donkey shell. The heating is carried out by adding the washed donkey shell to boiling water and heating the donkey shell for 15 to 25 minutes, And removing the hair, impurities, and oil layer remaining on the substrate.

또한, 상기 지방층의 제거는 당나귀 껍질의 콜라겐층과 지방층의 경계부분을 커팅기 등으로 절단하여 지방층을 콜라겐층으로부터 분리하는 단계로, 지방층이 제거된 후에는 다시 한번 흐르는 물에 수세하는 것이 바람직하다.In addition, the removal of the fat layer is a step of separating the fat layer from the collagen layer by cutting the collagen layer of the donkey's skin with a boundary portion between the fat layer and the like, and washing the fat layer with water once again after the fat layer is removed.

상기의 과정을 통해 털, 분순물 및 지방층 등이 제거된 당나귀 껍질은 상기 콜라겐분해단계에서 진행되는 효소분해 과정에서 지방층으로 인한 콜라겐분해를 억제현상이 발생하지 않기 때문에, 높은 수율로 콜라겐 분해물을 수득할 수 있다.
Since the donkey bark from which the hair, impurities and fat layer are removed through the above process does not inhibit the collagen degradation due to the fat layer during the degradation process of the collagen, the collagen degradation product is obtained at a high yield can do.

상기 콜라겐추출여과단계(S103)는 상기 원료전처리단계(S101)를 통해 전처리된 당나귀 껍질을 물과 혼합하고 고온고압을 가하여 콜라겐을 추출하고 여과하는 단계로, 더욱 상세하게는 상기 원료전처리단계(S101)를 통해 전처리된 당나귀 껍질 100 중량부를 물 150 내지 250 중량부와 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제1추출여과단계(S103-1) 및 상기 제1추출여과단계(S103-1)를 통해 콜라겐이 1차로 추출된 당나귀 껍질 100 중량부를 물 80 내지 120 중량부와 다시 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제2추출여과단계(S103-2)로 이루어지며, 상기 제1추출여과단계(S103-1) 및 상기 제2추출여과단계(S103-2)를 통해 여과된 추출물은 혼합하여 사용하는데, 상기와 같이 추출과정을 2회에 걸쳐 실시하게 되면, 당나귀의 껍질에 함유된 콜라겐의 추출효율성이 향상된다.The collagen extraction filtration step (S103) is a step of mixing the pretreated donkey bark with water and extracting collagen by applying high temperature and high pressure, and filtering the raw material, and more specifically, the raw material pre-treatment step S101 100 parts by weight of the donkey shell pretreated through the first extraction filtration step (150 to 250 parts by weight of water) is subjected to a first extraction filtration step of extracting and filtering at a temperature of 110 to 130 ° C and a pressure of 1 to 2 kgf / cm 2 for 50 to 70 minutes 100 parts by weight of the donkey shell, from which collagen has been first extracted, are mixed again with 80 to 120 parts by weight of water through the first extraction filtration step (S103-1) and the first extraction filtration step (S103-1) and a second extraction filtration step (S103-2) of extracting and filtering at 50 to 70 minutes at a pressure of 1 to 2 cm < 2 >. The first extraction filtration step (S103-1) and the second extraction filtration step (S103-2 ) Are mixed and used, When carried over the extraction process, as the group 2 times, thereby improving the extraction efficiency of the collagen contained in the skin of a donkey.

상기 제1추출여과단계(S103-1) 및 상기 제2추출여과단계(S103-2)에서 사용되는 여과장치는 100 내지 200 마이크로미터의 입자를 걸러낼 수 있는 필터를 사용하는 것이 바람직하다.It is preferable that the filter used in the first extraction filtration step (S103-1) and the second extraction filtration step (S103-2) be a filter capable of filtering particles of 100 to 200 micrometers.

상기의 과정으로 이루어지는 콜라겐추출여과단계(S103)를 거치면, 당나귀 껍질 추출물에 함유된 콜라겐 성분을 저렴한 비용과 우수한 수율 및 짤은 가공시간 내에 추출할 수 있다.
Through the collagen extraction filtration step (S103) comprising the above process, the collagen components contained in the donkey bark extract can be extracted at low cost, excellent yield, and short processing time.

상기 콜라겐분해단계(S105)는 상기 콜라겐추출여과단계(S103)를 통해 추출 및 여과된 콜라겐에 단백질분해효소를 혼합하여 콜라겐을 분해하는 단계로, 상기 콜라겐추출여과단계(S103)를 통해 추출 및 여과된 콜라겐 100 중량부에 단백질분해효소 0.05 내지 0.2 중량부를 혼합하고 40 내지 50℃의 온도에서 2 내지 4시간 동안 이루어진다.The collagen decomposition step (S105) is a step of decomposing collagen by mixing the proteolytic enzyme with the collagen extracted and filtered through the collagen extraction filtration step (S103). The collagen extraction filtration step (S103) And 0.05 to 0.2 parts by weight of proteolytic enzyme is mixed at a temperature of 40 to 50 DEG C for 2 to 4 hours.

상기 단백질분해효소의 함량이 0.05 중량부 미만이면, 콜라겐의 분해효율성이 저하되어 3kDa 이하의 저분자 펩타이드 형태의 콜라겐 생성비율이 낮아지고, 상기 단백질분해효소의 함량이 0.2 중량부를 초과하게 되면 콜라겐의 분해효율성은 크게 향상되지 않으면서 제조비용을 증가시키고, 상기 효소불활성화단계(S107)의 시간이 길어져 생산성 측면에서도 바람직하지 못하다.If the content of the protease is less than 0.05 part by weight, the degradation efficiency of collagen is lowered and the production rate of collagen in the form of a low molecular peptide of 3 kDa or less is lowered. When the content of the protease exceeds 0.2 part by weight, The efficiency is not greatly improved, but the manufacturing cost is increased, and the time of the enzyme inactivation step (S107) is prolonged, which is not preferable in terms of productivity.

또한, 상기 콜레겐분해단계(S105)에서 설정된 pH는 6.5 내지 7.5인 것이 바람직하며, 상기 콜라겐추출여과단계(S103)를 통해 추출 및 여과된 콜라겐을 단백질 분해 효소로 분해하는 과정을 통해 저분자 펩타이드로 분해된 콜라겐 효소 분해물을 얻을 수 있는데, 콜라겐 효소 분해물에 함유된 저분자 펩타이드의 함량이 높을수록 3kDa 이하 콜라겐 저분자 펩타이드 분해물의 수율을 높일 수 있다.In addition, the pH set in the collagen decomposition step (S105) is preferably 6.5 to 7.5, and the collagen extracted and filtered collagen is decomposed into proteolytic enzymes through the collagen extraction filtration step (S103) The degraded collagen enzyme degradation product can be obtained. The higher the content of the low molecular peptide contained in the collagen enzyme degradation product, the higher the yield of the collagen low molecular peptide degradation product of 3 kDa or less.

이때, 상기 단백질분해효소는 판크레아제와 알카린프로테아제가 1:1의 중량부로 혼합되어 이루어지는데, 상기 판크레아제는 돼지 췌장에서 유래한 것을 사용하는 것이 바람직하며, 상기 알카린프로테아제는 Bacillus licheniformis에서 유래한 Foodpro Alkalin Protease(原Protex 6L)을 사용하는 것이 바람직하다.
At this time, the protease is mixed with pancreatin and alkaline protease in a weight ratio of 1: 1. Preferably, the pancreatase is derived from a pancreas, and the alkaline protease is Bacillus licheniformis It is preferable to use Foodpro Alkalin Protease (original Protex 6L) derived from Escherichia coli.

상기 효소불활성화단계(S107)는 상기 콜라겐분해단계(S105)를 통해 분해된 콜라겐 분해물에 함유된 효소를 불활성화하는 단계로, 상기 콜라겐분해단계(S105)를 통해 분해된 콜라겐분해물을 85 내지 95℃의 온도로 10 내지 20분 동안 가열하여 이루어진다.The enzyme inactivation step (S107) is a step of inactivating the enzyme contained in the collagen degradation product decomposed through the collagen decomposition step (S105), and the collagen degradation product decomposed through the collagen decomposition step (S105) Lt; 0 > C for 10 to 20 minutes.

상기의 온도와 시간 동안 가열된 콜라겐 분해물에 함유되어 있는 단백질 효소는 불활성화가 진행된다.
The protein enzyme contained in the heated collagen decomposition product at the above temperature and time is inactivated.

상기 여과단계(S109)는 상기 효소불활성화단계(S107)를 통해 효소가 불활성화된 콜라겐 분해물을 여과하는 단계로, 상기 효소불활성화단계(S107)를 통해 효소가 불활성화된 콜라겐 분해물을 분자량이 3kDa를 초과하는 성분을 걸러낼 수 있는 맴브레인 필터로 여과하여, 피부 노화억제 및 주름 개선 효과가 우수한 3kDa 이하의 펩타이드의 형태를 갖는 저분자 콜라겐 분해물의 수율을 높이는 단계다.The step of filtering (S109) is a step of filtering the collagen degradation product in which the enzyme is inactivated through the enzyme inactivation step (S107). The collagen degradation product in which the enzyme is inactivated through the enzyme inactivation step (S107) It is a step to increase the yield of the low-molecular collagen degradation product in the form of a peptide of 3 kDa or less, which is excellent in skin aging inhibition and wrinkle-reducing effect by filtering with a membrane filter capable of filtering out components exceeding 3 kDa.

상기의 여과단계를 거치면, 3kDa 이하의 펩타이드의 형태를 갖는 저분자 콜라겐 분해물로 이루어진 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조가 완료되며, 상기의 과정을 통해 제조된 당나귀 껍질을 이용한 피부노화 억제용 조성물은 동결건조의 과정을 통해 분말형태로 보관하는 것이 바람직하다.Through the above filtration step, a composition for inhibiting skin aging using a donkey shell consisting of a low-molecular collagen degradation product having a peptide form of 3 kDa or less is completed, and a composition for inhibiting skin aging using the donkey skin prepared through the above- The composition is preferably stored in powder form through a lyophilization process.

상기의 과정을 통해 제조되는 당나귀 껍질을 이용한 피부노화 억제용 조성물은 일반적인 화장품의 제형인 크림, 로션, 에센스 및 토너 등과 같은 대부분의 화장품 제형에 적용가능하며, 상기와 같이 당나귀 껍질을 이용한 피부노화 억제용 조성물이 함유된 개시된 크림, 로션, 에센스 및 토너 등의 화장품은 피부노화 방지 및 주름 개선효과를 나타낸다.
The composition for inhibiting skin aging using the donkey skin produced through the above process can be applied to most cosmetic formulations such as creams, lotions, essences and toners, which are formulations of general cosmetics. As described above, Cosmetics such as creams, lotions, essences, and toners disclosed in the present invention exhibit anti-aging and anti-wrinkle effects.

이하에서는, 개시된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법 및 그 제조방법을 통해 제조된 피부노화 억제용 조성물의 물성을 실시예를 들어 설명하기로 한다.
Hereinafter, the method for producing a composition for inhibiting skin aging using the disclosed donkey skin and the physical properties of the composition for inhibiting skin aging prepared through the method will be described with reference to examples.

<실시예 1>&Lt; Example 1 >

당나귀 껍질을 흐르는 찬물에 수세한 후 100℃의 물에 20분 동안 가열하여 이물질(털 및 불순물 등)을 제거하고, 이물질이 제거된 당나귀 껍질에 지방층을 컷팅기로 제거한 후에 흐르는 찬물에 다시 수세한 다음 가로 1센티미처, 세로 0.5 센티미터의 크기로 절단하고, 절단된 당나귀 껍질 100g에 200ml의 물을 혼합하고 고온고압추출기로 121℃의 온도에서 1.5kgf/cm2의 압력으로 1시간 동안 1차 추출하고, 150 마이크로미터 이상의 입자를 여과할 수 있는 필터로 여과하여 1차 추출물을 제조하고, 1차 추출과정을 거친 당나귀 껍질에 여과물 100 중량부에 100ml의 물을 혼합하고 고온고압추출기로 121℃의 온도와 1.5kgf/cm2의 압력으로 1시간 동안 2차 추출하고, 150 마이크로미터 이상의 입자를 여과할 수 있는 필터로 여과한 후에, 상기 1차 추출물과 혼합하여 콜라겐 추출물을 제조하고, 제조된 콜라겐 추출물 100 중량부에 0.1 중량부의 단백질 분해효소{(돼지 판크립신(Pancripsin, 판크레아틴의 제품명, 비전바이오켐)과 푸드프로알칼린프로테아제(Foodpro alkaine protease, 이전 Protax 6L의 제품명, dupont genencor)} 0.1 중량부를 혼합하고, 45℃에서 3시간 동안 효소분해하고, 효소분해된 콜라겐 분해물을 90℃에서 10분간 효소불활성화한 후에, 맴브레인 필터를 이용하여 3kDa 이하의 저분자 효소분해물과 3kDa 초과 효소분해물로 분리하여 당나귀 껍질을 이용한 피부노화 억제용 조성물을 동결건조하여 분말형태로 제조하였다.
After washing with hot water flowing through the donkey's skin, it was heated in 100 ° C water for 20 minutes to remove foreign matter (hair and impurities), and the fat layer was removed by a cutting machine on the donkey skin removed from the foreign substance. And cut into a size of 0.5 cm in length and 1 cm in length. The cut donkey shells (100 g) were mixed with 200 ml of water and subjected to primary extraction at 121 ° C and a pressure of 1.5 kgf / cm 2 for 1 hour , And the particles having a particle size of 150 micrometers or more were filtered through a filter to prepare a first extract. 100 ml of water was mixed with 100 parts by weight of the filtrate and then with a high-temperature and high-pressure extractor at 121 ° C The mixture was subjected to secondary extraction at a temperature of 1.5 kgf / cm 2 for 1 hour, filtered through a filter capable of filtering at least 150 micrometers, mixed with the primary extract, Water was added to 100 parts by weight of the prepared collagen extract and 0.1 part by weight of proteinase {Pancripsin (product name of pancreatin, Vision BioChem) and Foodpro alkaine protease (former Protax 6L, product name: dupont genencor)}, and enzymatically decomposed at 45 ° C. for 3 hours. The enzyme-degraded collagen degradation product was inactivated at 90 ° C. for 10 minutes for enzyme treatment, and then a low molecular weight 3 kDa or less Enzyme degradation products and 3 kDa excess enzyme degradation products were prepared by freeze - drying the composition for inhibiting skin aging using donkey skin.

상기 실시예 1을 통해 제조된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 수율, 가수분해도 및 고형분의 함량을 측정하여 아래 표 1에 나타내었다.The yield, the degree of hydrolysis, and the content of solid content of the composition for inhibiting skin aging using the donkey shell prepared in Example 1 were measured and shown in Table 1 below.

[단, 수율(%)={가수분해물 동결건조후 무게(g)/원료무게(g)}×100의 계산법을 이용하였으며, 가수분해도(%)={10% TCA에 용해될 수 있는 sample의 단백질함량/sample 내 존재하는 총 단백질 함량}×100의 계산법을 이용하였으며, 고형분 함량(g/100g)=굴절당도계를 이용하여 측정하였다.]
[However, the yield (%) = we used the {hydrolyzate freeze weight after drying (g) / raw material weight (g)} The calculation of × 100, degree of hydrolysis (%) = a {sample in 10% soluble in TCA Protein content / total protein content present in sample} × 100, and the solids content (g / 100 g) was measured using a refractometric sugar meter.

<표 1><Table 1>

Figure 112016103819306-pat00001

Figure 112016103819306-pat00001

또한, 상기 실시예 1을 통해 제조된 당나귀 껍질을 이용한 피부노화 억제용 조성물의 3kDa이하 분말의 수율(%)과 3kDa초과 분말의 수율(%)을 측정하여 아래 표 2에 나타내었다.The yield (%) of the powder below 3 kDa and the yield (%) of the powder over 3 kDa of the composition for inhibiting skin aging using the donkey shell prepared in Example 1 were measured and shown in Table 2 below.

[단, 3kDa이하 분말의 수율(%)과 3kDa초과 분말의 수율(%)={맴브레인필터 여과 후 동결건조무게(g)/원료무게(g)}×의 계산법을 이용하였다.]
(The calculation of the yield (%) of the powder below 3 kDa and the yield (%) of the powder above 3 kDa = {the lyophilization weight after filtration of the membrane filter (g) / the weight of the raw material (g)

<표 2><Table 2>

Figure 112016103819306-pat00002

Figure 112016103819306-pat00002

또한, 상기 실시예 1을 통해 제조된 3kDa 초과 및 이하의 당나귀 껍질을 이용한 피부노화 억제용 조성물의 항산화 활성을 확인하고자 ORAC(Oxygen radical absorbance capacity)활성을 측정하였다. 당나귀 껍질 내 콜라겐 추출물로부터 추출 된 3kDa 이하의 당나귀 껍질을 이용한 피부노화 억제용 조성물(이하 '분말'이라 함)과 3kDa 초과 당나귀 껍질을 이용한 피부노화 억제용 조성물을 0.1, 0.2, 0.3 mg/ml의 농도로 희석하여 분석하였으며, 표준 시약으로서는 트롤록스(Trolox)를 이용하였다. 블랙 96 웰 플레이트(Black 96 well plate)에 각각의 시료와 표준시약 25㎕(마이크로리터)를 각각 넣고, 80nM 플루오르세인(Fluorescein) 150㎕를 각각 넣어 혼합한 뒤, 37℃ 인큐베이트(incubate)에서 15분 동안 방치하였다. 그 후 150mM AAPH(2,2'-Azobis(2-Amidinopropane) Dihydrochloride) 25㎕를 넣고 잘 혼합한 후에, 형광분광광도계(Fluorescent microplate reader)를 사용하여 37℃에서 여기 파장(Excitation wavelength) 485nm과 방사 파장(emission wavelength) 520nm에서 60분 동안 1분 간격으로 측정하였다. 그 후, 시료와 표준시약의 AUC(area under the curve)를 측정한 후에 표준시약 농도와 AUC 간의 회귀곡선을 이용하여 ㎛ Trolox equivalent를 측정하여 아래 도 2의 그래프로 나타내었다.The ORAC (Oxygen Radical Absorbance Capacity) activity was measured in order to examine the antioxidative activity of the composition for inhibiting skin aging using the donkey skin of 3 kDa or more prepared in Example 1 above. A composition for inhibiting skin senescence (hereinafter referred to as "powder") using a donkey shell of 3 kDa or less extracted from collagen extract in donkey skin and a composition for inhibiting skin senescence using a donkey shell of 3 kDa or more were coated at 0.1, 0.2 and 0.3 mg / ml , And Trolox was used as a standard reagent. Each sample and 25 μl (microliter) of a standard reagent were placed in a black 96-well plate and mixed with 150 μl of 80 nM Fluorescein. The mixture was incubated at 37 ° C. in an incubator And allowed to stand for 15 minutes. After that, 25 μl of 150 mM AAPH (2,2'-Azobis (2-Amidinopropane) Dihydrochloride) was added and mixed well. The mixture was well mixed at 485 nm excitation wavelength at 37 ° C. using a fluorescence microplate reader, The emission wavelength was measured at 520 nm for 60 minutes at 1 minute intervals. Thereafter, the area under the curve (AUC) of the sample and the standard reagent was measured, and a Trolox equivalent of 쨉 m was measured using a regression curve between the standard reagent concentration and the AUC.

아래 도 2에 나타낸 것처럼, 실험결과 3kDa 이하 분말이 모든 농도에서 3kDa 초과 분말 보다 높은 ORAC 활성을 나타내었다.As shown in FIG. 2 below, the experiment showed that the powder of 3 kDa or less exhibited higher ORAC activity than the powder of 3 kDa or more at all concentrations.

또한, 3kDa 이하 분말과 초과분말의 항산화 활성을 확인하고자 ABTS 라디칼 소거활성을 측정하였다. 3kDa 이하 분말과 3kDa 초과 분말을 0.5, 1, 5mg/ml의 농도로 희석하여 분석하였으며, 표준 시약으로서는 트롤록스(Trolox)를 이용하였다. 7mM ABTS 용액 10mL 및 2.45 포타슘 퍼설페이트(Potassium persulphate)용액 10mL를 혼합하고, ABTS+ 라디칼을 만들기 위해 실온에서 16시간 동안 암소 반응을 시켰다. 라디칼이 생성된 용액을 735nm에서 흡광도 값이 0.700±0.002가 되도록 희석하여 ABTS+ 용액을 제조하였다. 그 후, 각각의 시료 50㎕를 각각 혼합하여 30℃ 암실에서 30분간 반응시킨 뒤, 분광광도계(spectrophotometer)를 이용하여 735nm에서 흡광도를 측정하였다. ABTS 라디칼 소거활성은 트롤록스(Trolox)의 항산화 효과를 나타내는 M Trolox equivlent를 측정하여 아래 도 3의 그래프로 나타내었다.In addition, ABTS radical scavenging activity was measured to confirm the antioxidative activity of powders below 3 kDa and excess powder. 3 kDa powder and 3 kDa powder were diluted to 0.5, 1 and 5 mg / ml, and Trolox was used as a standard reagent. 10 mL of 7 mM ABTS solution and 10 mL of 2.45 potassium persulphate solution were mixed and subjected to a cow reaction at room temperature for 16 hours to make an ABTS + radical. The solution in which radicals were generated was diluted at 735 nm such that the absorbance value was 0.700 ± 0.002 to prepare an ABTS + solution. Thereafter, 50 각각 of each sample was mixed, reacted in a dark room at 30 캜 for 30 minutes, and the absorbance was measured at 735 nm using a spectrophotometer. The ABTS radical scavenging activity was measured by M Trolox equivlent, which shows the antioxidant effect of Trolox, and is shown in the graph of FIG. 3 below.

아래 도 3에 나타낸 것처럼, 실험결과 3kDa 이하 분말은 모든 농도에서 3kDa 초과 분말 보다 높은 ABTS 라디칼 소거 활성을 나타내었다.As shown in FIG. 3, below 3 kDa powder showed higher ABTS radical scavenging activity than 3 kDa powder at all concentrations.

또한, 3kDa 이하 분말 및 3kDa 초과 분말의 항산화 활성을 확인하고자 DPPH 라디칼 소거활성을 측정하였다. 3kDa 이하 분말과 3kDa 초과 분말을 5, 10, 20 mg/ml 의 농도로 희석하여 분석하였으며, 표준 시약으로서는 트롤록스(Trolox)를 이용하였다. 96 웰 플레이트(96 well plate)에 각각의 시료와 표준시약 100㎕를 각각 넣고, DPPH 용액 100㎕를 각각 넣어 혼합한 뒤, 암소 상온에서 30분간 반응시킨 다음 분광광도계(spectrophotometer)를 사용하여 517nm에서 흡광도를 측정하였다. DPPH 라디칼 소거능은 트롤록스(Trolox)를 표준물질로 하여, (μM) Trolox equivalent를 측정하여 아래 도 4의 그래프로 나타내었다.DPPH radical scavenging activity was also measured to confirm antioxidative activity of the powder below 3 kDa and the powder of over 3 kDa. 3 kDa powder and 3 kDa powder were diluted to 5, 10 and 20 mg / ml, and Trolox was used as a standard reagent. 100 μl of each sample and standard reagent was added to each well of a 96-well plate, and 100 μl of DPPH solution was added to each well. The mixture was reacted for 30 minutes at room temperature in a dark room and then subjected to spectrophotometry at 517 nm Absorbance was measured. The DPPH radical scavenging activity was measured using Trolox as a standard and (μM) Trolox equivalent, and the graph of FIG. 4 is shown below.

아래 도 4에 나타낸 것처럼, 실험결과, 3kDa 이하 분말이 모든 농도에서 3kDa 초과 분말 보다 높은 DPPH 라디칼 소거 활성을 나타내었다.As shown in FIG. 4, below 3 kDa powder showed DPPH radical scavenging activity higher than 3 kDa powder at all concentrations.

또한, 3kDa 이하 분말 및 3kDa 초과 분말의 항산화 활성을 확인하고자 FRAP(Ferric reducing anti-oxidants power)활성을 측정하였다. 3kDa 이하 분말과 3kDa 초과 분말의 유효성분을 5, 10, 20mg/ml의 농도로 희석하여 분석하였으며, 표준 시약으로서는 트롤록스(Trolox)를 이용하였다. 반응용액은 300mM 아세테이트 버퍼(acetate buffer, pH 3.6), 40mM HCl에 녹인 10mM TPTZ(2,4,6-tris(2-pyridyl)-s-triazine), 20mM FeCl3·6H2O를 각각 10:1:1의 중량부로 혼합하고 37℃의 온도를 유지하면서 사용하였다. 그 후 각각의 시료 및 표준시약 25㎕와 상기 반응 용액 175㎕를 각각 혼합하여 암실에서 5분간 방치한 후, 590nm에서 흡광도를 흑정하였다. FRAP 활성은 표준물질로 사용한 트롤록스(trolox) 농도에 상당하는 (μM) trolox equivalent로 측정하여 아래 도 5에 나타내었다.In addition, ferric reducing anti-oxidant power (FRAP) activity was measured to confirm the antioxidative activity of the powder below 3 kDa and the powder of 3 kDa excess. The active ingredient of the powder below 3 kDa and the powder of over 3 kDa was diluted to a concentration of 5, 10 and 20 mg / ml and analyzed. Trolox was used as a standard reagent. The reaction solution contained 10 mM TPTZ (2,4,6-tris (2-pyridyl) -s-triazine) and 20 mM FeCl 3 .6H 2 O dissolved in 40 mM acetate buffer (pH 3.6) 1: 1 by weight, and kept at a temperature of 37 캜. After that, 25 μl of each sample and standard reagent and 175 μl of the reaction solution were mixed and allowed to stand in a dark room for 5 minutes, and the absorbance was then quenched at 590 nm. The FRAP activity was measured as (μM) trolox equivalent, which corresponds to the concentration of trolox used as a standard, and is shown in FIG. 5 below.

아래 도 5에 나타낸 것처럼, 실험결과, 3kDa 이하 분말이 모든 농도에서 3kDa 초과 분말 보다 높은 FRAP 라디칼 소거 활성을 나타내었다.As shown in FIG. 5 below, the powder of 3 kDa or less showed FRAP radical scavenging activity higher than 3 kDa powder at all concentrations.

또한, 3kDa 이하 분말의 피부 주름 개선 효과를 확인하고자 엘라스테이스(elastase) 저해활성을 측정하였다. 시료로서 10, 50, 100, 200, 300 mg/ml의 농도로 고정한 3kDa 이하 분말을 이용하였다. 0.2M Tris-HCl buffer(pH 8) 120㎕, 1.0mM SANA(N-succinyl-(Ala)3-p-nitro anilide) 20㎕, 농도별 시료 100㎕를 각각 넣고, 25℃에서 10분간 배양한 다음, 1 U/mL의 농도인 돼지 췌장으로 분리한 엘라스테이스(Porcine pancreas elastase) 효소를 20㎕ 넣고, 25℃에서 20분간 반응시켰다. 그 후 분광광도계(spectrophotometer)를 이용하여 405nm에서 흡광도를 측정하여 아래 도 6에 나타내었다. 이때, 양성 대조군으로는 100㎍/mL의 우르솔릭산(ursolic acid)을 이용하였다. 또한, 엘라스테이스 저해활성은 다음과 같은 공식을 이용하였다.In addition, elastase inhibitory activity was measured in order to confirm the skin wrinkle improving effect of the powder of 3 kDa or less. As a sample, a powder of 3 kDa or less fixed at a concentration of 10, 50, 100, 200 or 300 mg / ml was used. 120 μl of 0.2 M Tris-HCl buffer (pH 8), 20 μl of 1.0 mM SANA (N-succinyl- (Ala) 3-p-nitroanilide) and 100 μl of each concentration sample were added and incubated at 25 ° C. for 10 minutes Then, 20 쨉 l of Porcine pancreas elastase enzyme, which had been separated from porcine pancreas at a concentration of 1 U / ml, was added and reacted at 25 캜 for 20 minutes. The absorbance was measured at 405 nm using a spectrophotometer and is shown in FIG. 6 below. At this time, 100 μg / mL of ursolic acid was used as a positive control. In addition, the following formula was used for the inhibition activity of the enzyme.

엘라스테이스 저해율(Elastase inhibition activity,%)=[1-{(sample OD-blank OD)/(control OD-blank OD)}×100]Elastase inhibition activity (%) = [1- (sample OD-blank OD) / (control OD-blank OD)} 100]

아래 도 6에 나타낸 것처럼, 실험결과, 농도 의존적으로 엘라스테이스 저해활성이 높았으며, 300mg/mL 농도의 3kDa 이하 분말이 가장 높은 엘라스테이스 저해 활성을 나타내었다.As shown in FIG. 6 below, the experiment showed that the inhibitory activity of the enzyme was high in a concentration-dependent manner, and the powder of less than 3 kDa at a concentration of 300 mg / mL showed the highest inhibitory activity of the enzyme.

또한, 3kDa 이하 분말의 피부 주름 개선 효과를 확인하고자 콜라게네이스(Collagenase)저해활성을 측정하였다. 시료로서 0.5, 1, 5, 10, 15, 20 mg/ml의 농도로 고정한 3kDa 이하 분말을 이용하였다. 0.3mg/ml 콜라게네이스 발색단(Collagenase Chromophore)기질 0.25mL에 농도별로 시료 0.1mL를 넣고 0.2mg/ml 콜라게네이스(Collagenase) 효소를 0.15mL 첨가하여 실온에서 20분간 방치한 후 6% 시트릭산(Citric acid) 0.5 mL를 넣어 효소반응을 정지시켰다. 그 후, 에틸아세테이트(ethylacetate) 1.5mL를 첨가하여 상등액을 320nm에서 흡광도를 측정하여 아래 도 7에 나타내었다. 콜라게네이스(Collagenase) 저해활성은 다음의 공식을 이용하여 계산하였다.In addition, collagenase inhibitory activity was measured in order to confirm the skin wrinkle improving effect of the powder below 3 kDa. As a sample, powders of 3 kDa or less fixed at concentrations of 0.5, 1, 5, 10, 15 and 20 mg / ml were used. 0.1 mL of a 0.2 mg / ml collagenase enzyme was added to 0.25 mL of a 0.3 mg / mL collagenase chromophore substrate, and the mixture was allowed to stand at room temperature for 20 minutes. Then, 6% citric acid 0.5 mL of citric acid was added to stop the enzyme reaction. Then, 1.5 mL of ethylacetate was added, and the supernatant was measured for absorbance at 320 nm and is shown in FIG. 7 below. Collagenase inhibitory activity was calculated using the following formula.

콜라게네이스 저해율(Collgaenase inhibition activity,%)=[1-{(sample OD-blank OD)/(control OD-blank OD)}×100]Collagenase inhibition activity (%) = [1 - {sample OD-blank OD) / (control OD-blank OD)} 100]

아래 도 7에 나타낸 것처럼, 실험결과, 농도 의존적으로 콜라게네이스(Collagenase) 저해활성이 높게 나타났다. 특히, 20mg/mL 농도의 3kDa 이하 분말이 가장 높은 콜라게네이스 저해 활성을 나타내었다.As shown in FIG. 7 below, the experiment showed that the collagenase inhibitory activity was high in a concentration-dependent manner. Particularly, the powder of 3 kDa or less at a concentration of 20 mg / mL showed the highest collagenase inhibitory activity.

상기와 같은 결과로 인해 3kDa 이하 분말은 우수한 피부 노화 억제 효과 및 피부 주름 개선 효과를 나타내는 것을 알 수 있었다.
As a result, the powder of 3 kDa or less showed excellent skin aging inhibition effect and skin wrinkle improving effect.

S101 ; 원료전처리단계
S103 ; 콜라겐추출여과단계
S103-1 ; 제1추출여과단계
S103-2 ; 제2추출여과단계
S105 ; 콜라겐분해단계
S107 ; 효소불활성화단계
S109 ; 여과단계
S101; Raw material pretreatment step
S103; Collagen extraction filtration step
S103-1; The first extraction filtration step
S103-2; The second extraction filtration step
S105; Collagen degradation step
S107; Enzyme inactivation step
S109; Filtration step

Claims (6)

당나귀 껍질을 전처리하는 원료전처리단계;
상기 원료전처리단계를 통해 전처리된 당나귀 껍질을 물과 혼합하고 고온고압을 가하여 콜라겐을 추출하고 여과하는 콜라겐추출여과단계;
상기 콜라겐추출여과단계를 통해 추출 및 여과된 콜라겐에 단백질분해효소를 혼합하여 콜라겐을 분해하는 콜라겐분해단계;
상기 콜라겐분해단계를 통해 분해된 콜라겐 분해물에 함유된 효소를 불활성화하는 효소불활성화단계; 및
상기 효소불활성화단계를 통해 효소가 불활성화된 콜라겐 분해물을 여과하는 여과단계;로 이루어지며,
상기 콜라겐추출여과단계는 상기 원료전처리단계를 통해 전처리된 당나귀 껍질 100 중량부를 물 150 내지 250 중량부와 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제1추출여과단계; 및
상기 제1추출여과단계를 통해 콜라겐이 추출된 당나귀 껍질 100 중량부를 물 80 내지 120 중량부와 혼합하고 110 내지 130℃의 온도와 1 내지 2kgf/cm2의 압력으로 50 내지 70분 동안 추출 및 여과하는 제2추출여과단계;로 이루어지며,
상기 효소불활성화단계는 상기 콜라겐분해단계를 통해 분해된 콜라겐분해물을 85 내지 95℃의 온도로 10 내지 20분 동안 가열하여 이루어지는 것을 특징으로 하는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법.
A raw material pretreatment step for pretreating the donkey shell;
A collagen extraction filtration step in which the donkey shell pretreated through the raw material pretreatment step is mixed with water and the collagen is extracted by applying a high temperature and a high pressure and then filtered;
A collagen decomposition step of decomposing collagen by mixing the proteolytic enzyme with the collagen extracted and filtered through the collagen extraction filtration step;
An enzyme inactivation step of inactivating the enzyme contained in the collagen degradation product decomposed through the collagen degradation step; And
And a filtration step of filtering the collagen decomposition product in which the enzyme is inactivated through the enzyme inactivation step,
100 parts by weight of the donkey shell pretreated through the raw material pretreatment step is mixed with 150 to 250 parts by weight of water and extracted at a temperature of 110 to 130 ° C and a pressure of 1 to 2 kgf / cm 2 for 50 to 70 minutes And a first extraction and filtering step of filtering; And
The first extraction the collagen is extracted donkey shell 100 weight through filtration step parts of water of 80 to 120 parts by weight of the mixture, and the temperature and 1 to a pressure of 2kgf / cm 2 of 110 to 130 ℃ 50 to 70 minutes extraction for and filtration And a second extraction and filtration step,
Wherein the enzyme inactivation step comprises heating the collagen degradation product decomposed through the collagen decomposition step at a temperature of 85 to 95 DEG C for 10 to 20 minutes.
삭제delete 청구항 1에 있어서,
상기 콜라겐분해단계는 상기 콜라겐추출여과단계를 통해 추출 및 여과된 콜라겐 100 중량부에 단백질분해효소 0.05 내지 0.2 중량부를 혼합하고 40 내지 50℃의 온도에서 2 내지 4시간 동안 이루어지는 것을 특징으로 하는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법.
The method according to claim 1,
Wherein the collagen decomposition step is performed by mixing 0.05 to 0.2 parts by weight of a protease with 100 parts by weight of collagen extracted and filtered through the collagen extraction filtration step at a temperature of 40 to 50 DEG C for 2 to 4 hours. A method for preparing a composition for inhibiting skin aging using the same.
청구항 1 또는 3에 있어서,
상기 단백질분해효소는 판크레아제와 알카린프로테아제가 1:1의 중량부로 혼합되어 이루어지는 것을 특징으로 하는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법.
The method according to claim 1 or 3,
Wherein the proteinase is a mixture of pancreatin and alkaline protease in a weight ratio of 1: 1.
삭제delete 청구항 1에 있어서,
상기 여과단계는 분자량이 3kDa를 초과하는 성분을 걸러낼 수 있는 맴브레인 필터로 이루어지는 것을 특징으로 하는 당나귀 껍질을 이용한 피부노화 억제용 조성물의 제조방법.
The method according to claim 1,
Wherein the filtration step comprises a membrane filter capable of filtering out components having a molecular weight exceeding 3 kDa.
KR1020160139335A 2016-10-25 2016-10-25 Manufacturing method of composition for inhibiting skin aging using donkey skin KR101814744B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160139335A KR101814744B1 (en) 2016-10-25 2016-10-25 Manufacturing method of composition for inhibiting skin aging using donkey skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160139335A KR101814744B1 (en) 2016-10-25 2016-10-25 Manufacturing method of composition for inhibiting skin aging using donkey skin

Publications (1)

Publication Number Publication Date
KR101814744B1 true KR101814744B1 (en) 2018-01-03

Family

ID=61002193

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160139335A KR101814744B1 (en) 2016-10-25 2016-10-25 Manufacturing method of composition for inhibiting skin aging using donkey skin

Country Status (1)

Country Link
KR (1) KR101814744B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102014949B1 (en) 2018-03-02 2019-08-27 강원대학교 산학협력단 Anti-oxidant peptide from ass skin glue
CN112812175A (en) * 2021-02-02 2021-05-18 江南大学 Application of high-glutamic acid donkey collagen active peptide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101525876B1 (en) * 2015-02-11 2015-06-03 소망화장품주식회사 Method for making glue from donkey skin and cosmetics containing the same
KR101635186B1 (en) 2011-12-29 2016-06-30 산둥 동-이 이-지아오 컴퍼니 리미티드 Active small-molecule donkey-hide gelatin mixture and preparation method and application thereof
KR101645238B1 (en) 2015-11-11 2016-08-03 강원대학교산학협력단 Cosmetic composition for anti-wrinkle or elasticity of skin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101635186B1 (en) 2011-12-29 2016-06-30 산둥 동-이 이-지아오 컴퍼니 리미티드 Active small-molecule donkey-hide gelatin mixture and preparation method and application thereof
KR101525876B1 (en) * 2015-02-11 2015-06-03 소망화장품주식회사 Method for making glue from donkey skin and cosmetics containing the same
KR101645238B1 (en) 2015-11-11 2016-08-03 강원대학교산학협력단 Cosmetic composition for anti-wrinkle or elasticity of skin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102014949B1 (en) 2018-03-02 2019-08-27 강원대학교 산학협력단 Anti-oxidant peptide from ass skin glue
CN112812175A (en) * 2021-02-02 2021-05-18 江南大学 Application of high-glutamic acid donkey collagen active peptide

Similar Documents

Publication Publication Date Title
CN108473980B (en) Topical composition comprising an extract of small RNA clanis bilineata and cosmetic care method for reducing signs of skin aging
EP3038715B1 (en) A composition comprising guacatonga extract and aroeira extract, use thereof for preventing and/or treating skin ageing
EP2335685A1 (en) Skin-whitening agent, anti-aging agent, and skin cosmetic
KR102036532B1 (en) Cosmetic treatment methods to protect skin from contamination and improve skin regeneration
KR101814744B1 (en) Manufacturing method of composition for inhibiting skin aging using donkey skin
KR20110006444A (en) Sargassum sp. extract that have low photo-induced cytotoxicity, preparation method thereof and cosmetic composition containing the same
JP2008285422A (en) Dna damage inhibitor and glutathione production promoter
Rivera et al. Biocompounds from rapeseed oil industry co‐stream as active ingredients for skin care applications
KR101356535B1 (en) Ulva spp seaweed hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same
Ding et al. Hyaluronidase inhibitory and antioxidant activities of enzymatic hydrolysate from Jeju Island red sea cucumber (Stichopus japonicus) for novel anti-aging cosmeceuticals
KR20150067015A (en) Cosmetic composition for improving anti-oxidation, whitening and anti-allergic containing the extract of Broom
KR101585913B1 (en) Method for production of horse leg bone extract and cosmetic composition with the extract of horse leg bone
KR101900717B1 (en) Cosmetic composition with small molecule gelatin peptide from donkey bone for anti-wrinkle and anti-aging of skin
KR102215192B1 (en) Cosmetic composition comprising a synergistic trf2 protein activation system consisting of a combination of a peptidic soybean and yeast extract and the uses thereof
KR101805872B1 (en) Cosmetic composition for improving skin wrinkle containing plant extract removed chlorophyll
KR101721944B1 (en) A cosmetic composition comprising enzymatic extracts from soft coral
KR101656928B1 (en) Composition for protecting skin against UV light and wrinkle improvement comprising the extract of Polygonum viscoferum
ES2612261T3 (en) Use of a composition comprising a peptide hydrolyzate of unfermented rice to stimulate hair growth
KR20210055475A (en) A composition for improving skin beauty containing glycosaminoglycan
WO2013136174A1 (en) Cosmetic use of an oat extract as an activating agent of caspase-14
KR20200016813A (en) Composition for skin whitening comprising enzymatic hydrolysates of insect
KR102298173B1 (en) A composition for improving skin beauty containing glycosaminoglycan extracted from insect
KR102041958B1 (en) Composition for skin-whitening containing mixed extracts as a active ingredients, and manufacturing method for composition and cosmetic composition
KR100379984B1 (en) Composition for whitening of skin and suppressing of aging containing extract of Zanthoxylum piperitum seed coat
KR102667277B1 (en) Extract of Moringa peregrina seed cake, process for its preparation and use thereof in cosmetic or nutricosmetic compositions

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant